vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and GEN Restaurant Group, Inc. (GENK). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $49.7M, roughly 1.7× GEN Restaurant Group, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -3.8%, a 26.6% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -9.0%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-5.6M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -1.0%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Gen Korean BBQ is an American chain of all-you-can-eat Korean barbecue restaurants mainly concentrated around the Western U.S. It opened in 2011, and has since grown to 43 locations as of 2024.
FDMT vs GENK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $49.7M |
| Net Profit | $19.4M | $-1.9M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | -24.5% |
| Net Margin | 22.8% | -3.8% |
| Revenue YoY | 8508900.0% | -9.0% |
| Net Profit YoY | 139.1% | -821.4% |
| EPS (diluted) | $0.43 | $-0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $49.7M | ||
| Q3 25 | $90.0K | $50.4M | ||
| Q2 25 | $15.0K | $55.0M | ||
| Q1 25 | $14.0K | $57.3M | ||
| Q4 24 | $1.0K | $54.7M | ||
| Q3 24 | $3.0K | $49.1M | ||
| Q2 24 | $5.0K | $53.9M | ||
| Q1 24 | $28.0K | $50.8M |
| Q4 25 | $19.4M | $-1.9M | ||
| Q3 25 | $-56.9M | $-566.0K | ||
| Q2 25 | $-54.7M | $-261.0K | ||
| Q1 25 | $-48.0M | $-301.0K | ||
| Q4 24 | — | $-206.0K | ||
| Q3 24 | $-43.8M | $25.0K | ||
| Q2 24 | $-35.0M | $277.0K | ||
| Q1 24 | $-32.4M | $496.0K |
| Q4 25 | 17.3% | -24.5% | ||
| Q3 25 | -67983.3% | -7.4% | ||
| Q2 25 | -396373.3% | -3.4% | ||
| Q1 25 | -383007.1% | -3.8% | ||
| Q4 24 | — | -2.4% | ||
| Q3 24 | -1704400.0% | 0.2% | ||
| Q2 24 | -849120.0% | 3.0% | ||
| Q1 24 | -136200.0% | 0.2% |
| Q4 25 | 22.8% | -3.8% | ||
| Q3 25 | -63195.6% | -1.1% | ||
| Q2 25 | -364386.7% | -0.5% | ||
| Q1 25 | -342657.1% | -0.5% | ||
| Q4 24 | — | -0.4% | ||
| Q3 24 | -1461433.3% | 0.1% | ||
| Q2 24 | -699060.0% | 0.5% | ||
| Q1 24 | -115717.9% | 1.0% |
| Q4 25 | $0.43 | $-0.37 | ||
| Q3 25 | $-1.01 | $-0.11 | ||
| Q2 25 | $-0.98 | $-0.05 | ||
| Q1 25 | $-0.86 | $-0.06 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-0.79 | $0.01 | ||
| Q2 24 | $-0.63 | $0.06 | ||
| Q1 24 | $-0.66 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $2.8M |
| Total DebtLower is stronger | — | $13.6M |
| Stockholders' EquityBook value | $505.7M | $26.5M |
| Total Assets | $566.7M | $259.9M |
| Debt / EquityLower = less leverage | — | 0.51× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $2.8M | ||
| Q3 25 | $305.1M | $4.8M | ||
| Q2 25 | $293.2M | $9.6M | ||
| Q1 25 | $321.4M | $15.4M | ||
| Q4 24 | $424.9M | $23.7M | ||
| Q3 24 | $501.9M | $22.1M | ||
| Q2 24 | $541.9M | $29.2M | ||
| Q1 24 | $525.9M | $28.1M |
| Q4 25 | — | $13.6M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $6.5M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | — | $7.2M | ||
| Q2 24 | — | $7.6M | ||
| Q1 24 | — | $7.7M |
| Q4 25 | $505.7M | $26.5M | ||
| Q3 25 | $369.0M | $38.1M | ||
| Q2 25 | $420.9M | $41.0M | ||
| Q1 25 | $469.7M | $42.8M | ||
| Q4 24 | $510.6M | $44.1M | ||
| Q3 24 | $552.9M | $46.5M | ||
| Q2 24 | $588.3M | $45.9M | ||
| Q1 24 | $600.6M | $40.4M |
| Q4 25 | $566.7M | $259.9M | ||
| Q3 25 | $424.0M | $245.5M | ||
| Q2 25 | $473.6M | $246.3M | ||
| Q1 25 | $515.7M | $232.4M | ||
| Q4 24 | $560.4M | $240.4M | ||
| Q3 24 | $604.0M | $225.7M | ||
| Q2 24 | $620.1M | $218.8M | ||
| Q1 24 | $629.9M | $214.5M |
| Q4 25 | — | 0.51× | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $-426.0K |
| Free Cash FlowOCF − Capex | $28.5M | $-5.6M |
| FCF MarginFCF / Revenue | 33.5% | -11.3% |
| Capex IntensityCapex / Revenue | 0.1% | 10.5% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $-24.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $-426.0K | ||
| Q3 25 | $-46.5M | $-1.6M | ||
| Q2 25 | $-43.4M | $3.3M | ||
| Q1 25 | $-47.8M | $2.2M | ||
| Q4 24 | $-134.6M | $7.3M | ||
| Q3 24 | $-29.4M | $1.4M | ||
| Q2 24 | $-30.2M | $5.6M | ||
| Q1 24 | $-29.1M | $3.5M |
| Q4 25 | $28.5M | $-5.6M | ||
| Q3 25 | $-46.6M | $-7.7M | ||
| Q2 25 | $-43.4M | $-6.3M | ||
| Q1 25 | $-48.4M | $-4.7M | ||
| Q4 24 | $-138.4M | $165.0K | ||
| Q3 24 | $-31.2M | $-6.8M | ||
| Q2 24 | $-30.6M | $1.2M | ||
| Q1 24 | $-29.8M | $-586.0K |
| Q4 25 | 33.5% | -11.3% | ||
| Q3 25 | -51765.6% | -15.3% | ||
| Q2 25 | -289620.0% | -11.5% | ||
| Q1 25 | -345635.7% | -8.2% | ||
| Q4 24 | -13837100.0% | 0.3% | ||
| Q3 24 | -1038966.7% | -13.9% | ||
| Q2 24 | -611840.0% | 2.3% | ||
| Q1 24 | -106421.4% | -1.2% |
| Q4 25 | 0.1% | 10.5% | ||
| Q3 25 | 101.1% | 12.0% | ||
| Q2 25 | 440.0% | 17.5% | ||
| Q1 25 | 4507.1% | 11.9% | ||
| Q4 24 | 378600.0% | 13.1% | ||
| Q3 24 | 59266.7% | 16.9% | ||
| Q2 24 | 6980.0% | 8.0% | ||
| Q1 24 | 2535.7% | 8.1% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 57.96× | ||
| Q2 24 | — | 20.06× | ||
| Q1 24 | — | 7.08× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
